NCT04948333 2026-03-18Asciminib Treatment Optimization in ≥ 3rd Line CML-CPNovartisPhase 3 Completed199 enrolled 13 charts
NCT02730299 2026-02-25Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDSGamida Cell ltdPhase 3 Completed125 enrolled 18 charts 1 FDA
NCT00254423 2026-01-15Dasatinib in Treating Patients With Early Chronic Phase Chronic Myelogenous LeukemiaM.D. Anderson Cancer CenterPhase 2 Completed150 enrolled 10 charts